Early Intervention in Multiple Sclerosis
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 63 (15) , 1525-1533
- https://doi.org/10.2165/00003495-200363150-00001
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cost-utility of interferon β 1b in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosisThe European Journal of Health Economics, 2003
- Cost-Effectiveness Analysis of Interferon Beta in Multiple Sclerosis: A Markov Process AnalysisValue in Health, 2002
- Cost and health related quality of life consequences of multiple sclerosisMultiple Sclerosis Journal, 2000
- Escalating Immunotherapy of Multiple SclerosisEuropean Neurology, 1999
- Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosisAnnals of Neurology, 1998
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Economic Evaluation of Multiple Sclerosis in the UK, Germany and FrancePharmacoEconomics, 1998
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Rating neurologic impairment in multiple sclerosisNeurology, 1983